HEALTH● LOWJul 10 · Jul 10, 2026, 11:29 AM
GSK partner Hansoh posts late-stage trial win for lung cancer drug in China
Seeking Alpha Tech
A partner of GSK, Hansoh, has successfully completed a late-stage trial for a lung cancer drug in China. This development marks progress in the pharmaceutical industry's efforts to treat lung cancer.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH45m agoRed hexagon on your snack pack: What FSSAI’s new proposed warning label means | ExplainedThe HinduHEALTH2h agoRotten meat, spoiled milk seized across Bengal as food safety raids widenThe HinduHEALTH2h ago'Social jet lag': Why mismatched sleep schedules could be fuelling anxiety in teenagersEuroNews [en]HEALTH2h agoRiverview Farms expansion endangers clean water , public healthminnpost.com · United States